143 related articles for article (PubMed ID: 20174844)
1. CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists.
Cichero E; Cesarini S; Mosti L; Fossa P
J Mol Model; 2010 Sep; 16(9):1481-98. PubMed ID: 20174844
[TBL] [Abstract][Full Text] [Related]
2. CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists.
Cichero E; Cesarini S; Mosti L; Fossa P
J Mol Model; 2010 Apr; 16(4):677-91. PubMed ID: 19809837
[TBL] [Abstract][Full Text] [Related]
3. Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Romero-Parra J; Chung H; Tapia RA; Faúndez M; Morales-Verdejo C; Lorca M; Lagos CF; Di Marzo V; David Pessoa-Mahana C; Mella J
Eur J Pharm Sci; 2017 Apr; 101():1-10. PubMed ID: 28137469
[TBL] [Abstract][Full Text] [Related]
4. Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors.
De Freitas GB; da Silva LL; Romeiro NC; Fraga CA
Eur J Med Chem; 2009 Jun; 44(6):2482-96. PubMed ID: 19249138
[TBL] [Abstract][Full Text] [Related]
5. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
6. 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.
Dessalew N; Singh SK
Med Chem; 2008 Jul; 4(4):313-21. PubMed ID: 18673142
[TBL] [Abstract][Full Text] [Related]
7. 3D QSAR studies on substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonist.
Vyas VK; Ghate M; Chintha C; Patel P
Curr Comput Aided Drug Des; 2013 Sep; 9(3):433-45. PubMed ID: 24010938
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling in tandem with 3D-QSAR analyses: a computational approach to depict the agonist binding site of the human CB2 receptor.
Cichero E; Ligresti A; Allarà M; di Marzo V; Lazzati Z; D'Ursi P; Marabotti A; Milanesi L; Spallarossa A; Ranise A; Fossa P
Eur J Med Chem; 2011 Sep; 46(9):4489-505. PubMed ID: 21835510
[TBL] [Abstract][Full Text] [Related]
9. New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists.
Pagé D; Yang H; Brown W; Walpole C; Fleurent M; Fyfe M; Gaudreault F; St-Onge S
Bioorg Med Chem Lett; 2007 Nov; 17(22):6183-7. PubMed ID: 17884494
[TBL] [Abstract][Full Text] [Related]
10. In-silico designing and characterization of binding modes of two novel inhibitors for CB1 receptor against obesity by classical 3D-QSAR approach.
Khan N; Halim SA; Khan W; Zafar SK; Ul-Haq Z
J Mol Graph Model; 2019 Jun; 89():199-214. PubMed ID: 30908997
[TBL] [Abstract][Full Text] [Related]
11. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of some benzimidazole derivatives with trichomonicidal activity.
Pérez-Villanueva J; Medina-Franco JL; Caulfield TR; Hernández-Campos A; Hernández-Luis F; Yépez-Mulia L; Castillo R
Eur J Med Chem; 2011 Aug; 46(8):3499-508. PubMed ID: 21621311
[TBL] [Abstract][Full Text] [Related]
12. Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors.
Peddi SR; Peddi SR; Sivan S; Veerati R; Manga V
J Recept Signal Transduct Res; 2020 Feb; 40(1):1-14. PubMed ID: 31931654
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, pharmacological evaluation and in silico ADMET prediction of novel substituted benzimidazole derivatives as angiotensin II-AT1 receptor antagonists based on predictive 3D QSAR models.
Vyas VK; Gupta N; Ghate M; Patel S
SAR QSAR Environ Res; 2014; 25(2):117-46. PubMed ID: 24598006
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole CB2 agonists: design, synthesis and SAR.
Nanda KK; Henze DA; Della Penna K; Desai R; Leitl M; Lemaire W; White RB; Yeh S; Brouillette JN; Hartman GD; Bilodeau MT; Trotter BW
Bioorg Med Chem Lett; 2014 Feb; 24(4):1218-21. PubMed ID: 24461289
[TBL] [Abstract][Full Text] [Related]
15. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
[TBL] [Abstract][Full Text] [Related]
16. 3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.
Chen JZ; Han XW; Liu Q; Makriyannis A; Wang J; Xie XQ
J Med Chem; 2006 Jan; 49(2):625-36. PubMed ID: 16420048
[TBL] [Abstract][Full Text] [Related]
17. Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.
Cichero E; Cesarini S; Spallarossa A; Mosti L; Fossa P
J Mol Model; 2009 Jul; 15(7):871-84. PubMed ID: 19153780
[TBL] [Abstract][Full Text] [Related]
18. 3D QSAR pharmacophore, CoMFA and CoMSIA based design and docking studies on phenyl alkyl ketones as inhibitors of phosphodiesterase 4.
Gaurav A; Singh R
Med Chem; 2012 Sep; 8(5):894-912. PubMed ID: 22741782
[TBL] [Abstract][Full Text] [Related]
19. 3D-QSAR CoMFA/CoMSIA studies on Urokinase plasminogen activator (uPA) inhibitors: a strategic design in novel anticancer agents.
Bhongade BA; Gadad AK
Bioorg Med Chem; 2004 May; 12(10):2797-805. PubMed ID: 15110861
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as glycogen synthase kinase-3beta inhibitors.
Dessalew N; Patel DS; Bharatam PV
J Mol Graph Model; 2007 Mar; 25(6):885-95. PubMed ID: 17018257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
